Clinical P pharmaphorum
Oura smart ring to be used in weight-loss outcomes trial
Oura smart ring to be used in weight-loss outcomes trial Phil.Taylor Thu, 29/10/2026 - 12:32
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Clinical P pharmaphorum
Oura smart ring to be used in weight-loss outcomes trial Phil.Taylor Thu, 29/10/2026 - 12:32
Clinical
Clinical Trials Arena
Arriving after rivals offering smaller PFS gains but fewer serious adverse events, iza-bren will need its early OS advantage to hold. The post ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide appeared first on Clinical Trials Arena.
Regulatory
EMA Press
EMA’s office is closed on Monday 2 November, to mark All Souls' Day. The office reopens at 08:30 on Tuesday 3 November.The product emergency hotline is available outside…
Industry
Pharmaceutical Technology
Reaction from the life sciences industry to the Autumn Budget was mixed, with the government opting for a more macro focus on business scaling.
Software S Science News
Some call for redefining requirements for authorship
Clinical
Clinical Trials Arena
Following this positive data, Sobi will now look ahead to its second pivotal readout for pozdeutinurad in uncontrolled gout. The post Sobi’s gout drug shows durability in Phase III study appeared first on Clinical Trials Arena.
Clinical
Clinical Trials Arena
This week's podcast features the Clinical Trials Arena team and GlobalData analysts who discuss the biggest study readouts from the ESMO Congress 2026. The post Podcast: ESMO26: Major readouts from the 2026 congress appeared first on Clinical Trials Arena.
Industry P Pharmafile
Onicor, a medical technology company developing a personalised treatment for onychomycosis (fungal nail infection), has appointed Piet De Doncker as its new Chief Executive Officer. He succeeds co-founder Ronald van der Geest, PhD, who led the company from its inception and…
Industry P pharmaphorum
HHS doubles down on controversial peptides plan Phil.Taylor Thu, 29/10/2026 - 11:24
Clinical
Clinical Trials Arena
Experts at OCT & CTS Nordics 2026 noted that strategic planning is non-negotiable in the midst of events like conflict and extreme weather. The post Navigating the complexities of running clinical trials amid disruption appeared first on Clinical Trials Arena.
Research A Applied Clinical Trials
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
Software C ChEMBL-og
We are pleased to announce the publication of our latest SureChEMBL paper, "SureChEMBL in 2026: an open database of chemical and biomedical annotations from the patent literature", in Nucleic Acids Research.The paper presents a major redesign of SureChEMBL, including modernised i…
Industry
C&EN Pharmaceuticals
The venture firm has combined 3 platforms into 1
Industry
BioPharma Dive
Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability to better predict the way new medicines will fare in humans.
Funding P pharmaphorum
UK budget includes £1bn biopharma investment package Phil.Taylor Thu, 29/10/2026 - 10:16
Regulatory
Clinical Trials Arena
United Therapeutics has received clearance from the US FDA under an IND to initiate a Phase I trial assessing Treprostinil-Iloprost SMI as a potential treatment for PAH. The post United Therapeutics secures FDA clearance for PAH Phase I trial appeared first on Clinical Trials Are…
Industry
Pharmaceutical Technology
Enthorin has signed an option-to-license deal with Rumi to advance ENT-7340 for FXS, as well as other intellectual and developmental disabilities.
Industry
Inside Precision Medicine
An atlas of more than 850,000 nuclei revealed distinct cellular and genetic features in early-onset colorectal cancer, including changes associated with aggressive tumor behavior and poorer outcomes. The post Single-Cell Analysis Reveals Distinct Biology of Early-Onset Colorectal…
Research B BioTechniques
Take a peek behind the paper: A refined qPCR duplexing method for the molecular sex determination of sturgeon (Acipenser genus), providing a validating, endogenous control. Recently published in BioTechniques, this work introduces an optimized qPCR duplexing method for sex i…
Industry P Pharmaceutical Executive
Shionogi’s Dr. Draica on why mild COVID-19 can worsen chronic conditions for up to a year — and why prevention matters more than hospitalization data suggests.
Clinical A Applied Clinical Trials
In today’s ACT Brief, we examine why anti-kickback guidance and EHR-integrated trial matching must work together in community settings, why real-time trials depend on mature risk-based quality management, and how pharma is applying digital clones to predict outcomes.
Software P Pharmaceutical Executive
Brock.AI’s Hamish Brocklebank on recruiting 8% of all US pancreatic cancer prescribers — paying $2,000 an hour, offering equity, and triple opt-in consent.
Software P Pharmaceutical Executive
As AI accelerates drug discovery, the industry’s next challenge is building a connected, standards-based data infrastructure capable of supporting it through clinical development.
Clinical
Clinical Trials Arena
Nacuity Pharmaceuticals has dosed the first patient in its global confirmatory Phase III SLO-RP Preserve study evaluating NPI-001 for RP associated with Usher syndrome. The post First patient dosed in Nacuity’s Phase III Usher syndrome RP trial appeared first on Clinical Trials A…
Industry
Pharmaceutical Technology
Formation Bio has launched the Formation Bio Drug Development Accelerator Fund to broaden the company's clinical-stage medicines portfolio.
Industry B BioTechniques
Original story from Carnegie Mellon University (PA, USA). Biological clocks are often associated with light. Historically, most people start their days when the Sun is up, and end their days when the sun sets. But new research from Carnegie Mellon University (PA, USA) suggests th…
Industry P Pharmafile
A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access treatment sooner and ease pressure on hospital lipid clinics. Led by Barts Health NHS Trust and UCLPartners, with funding from the British Heart Foundation (B…
Industry
European Biotechnology
Portugal-based Exogenus Therapeutics will lead a five-year, €13 million Horizon Europe project to advance its osteoarthritis candidate EXO-101 into clinical testing. The post Exogenus secures €13M EU consortium backing for secretome therapy in osteoarthritis appeared first on Eur…
Industry
STAT Biotech
An exemption for a common kind of biopharma deal is at the heart of disagreements over the proposal.
Industry
European Biotechnology
New biologic logic – Multispecific antibodies extend targeted therapy beyond one antigen or pathway. By combining binding sites, cell recruitment and defined valencies within one molecule, they enable mechanisms that conventional monoclonal antibodies or their combinations cannot…
Industry P pharmaphorum
Global oncology innovation from Hengrui Pharma Nicole.Raleigh Thu, 29/10/2026 - 08:00
Industry P Patent Docs
By Michael Borella – Grab a pencil. Now train a large language model. Not a big one, mind you. Let’s go small, something in the range of a few billion parameters, trained on a modest corpus of a trillion or so tokens. Conservatively, that run requires something…
Industry
BioSpace
Looking for a biopharma job in New York? Jobs on BioSpace have soared year over year and month over month.
Manufacturing
BioSpace
As companies invest billions of dollars to reshore manufacturing, 10 biotech and pharma businesses are reportedly trimming staff at manufacturing locations in 2026 or the coming years, with BioNTech having the deepest cuts.
Research B BioPharm International
Webinar Date/Time: Wed, Nov 18, 2026 11:00 AM EST
Clinical B BioPharm International
Webinar Date/Time: Thu, Nov 19, 2026 11:00 AM EST
Industry S Science News
Dozens of academics become politicians after student group’s stunning victory
Industry F FDA Law Blog
By James E. Valentine & Gayatri R. Rao & Frank J. Sasinowski —
Software O Omics! Omics!
Today marks two decades since I started writing here. It is not a coincidence that it is also twenty years since I was officially notified by Millennium Pharmaceuticals that my services would soon be no longer needed. Millennium had a strict no social media policy. Wh…
Software B BLOPIG
AKA why a protein does not naturally fit neatly into a tensor, and how RFdiffusion3, BoltzGen and La-Proteina cope when the amino-acid sequence is not known yet The problem: proteins are not rectangles Neural networks like fixed-shape arrays. Proteins are not fixed-shape: the 20…